AndhraNews.net
Home » Business News » 2013 » May » May 30, 2013

Ergoresearch Ltd (TSXV:ERG) is the Subject of StockPotentials Report by eResearch Corp - Video Summary of Report Posted on InvestmentPitch.com


May 30, 2013 - London

Vancouver, British Columbia, May 29, 2013 - Ergoresearch Ltd. (TSXV:ERG) was recently the subject of a StockPotentials report by Toronto-based eResearch Corporation. StockPotentials reports cover smaller companies that eResearch believes would be primarily of interest to retail investors.

InvestmentPitch.com has produced a "video news alert" about Ergoresearch based on this report. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Ergoresearch" in the search box

Based in Quebec, the company has built the province's leading network of orthotics clinics with over 100 corporate and satellite centres, which operate under a number of names.

The company is also the leading manufacturer of "intelligent" foot orthotics and specialty orthotics, and creates durable medical equipment and software for the orthopedics market.

Through a subsidiary, Ergoresearch has recently acquired Victhom Human Bionics Inc., a developer of innovative bionic devices, including the Power Knee, the only motorized prosthetic artificial intelligence for above-knee amputees.

Dr. Sylvain Boucher, President and CEO of Ergoresearch stated, "This acquisition enriches Ergoresearch's offering by reinforcing our position as a leader in the field of manufacture of "intelligent" foot orthotics and specialty orthotics. The complementary nature of our technology and our expertise will allow us to offer an even wider range of solutions to our customers and to better position Ergoresearch in terms of future national and international development."

In addition to its orthotics clinics, the company has developed, and markets a number of new orthotics products, including ExpertFit, the first robotized custom-fit orthotics manufacturing software program. The system enables the mass production of custom-fit 3D orthotics by using numerically-controlled machine tools, and computer-assisted manufacturing and design software. This results in a much faster and more accurate fabrication process compared with the traditional plaster-cast and foam-box process used in the industry.

At its Laval, Quebec, facility, the company has established its Living Lab, a facility aimed at the prevention and treatment of knee osteoarthritis.

The company recently reported its 24th consecutive quarterly profit, and expects to double its revenues over the next 12 months. It recently closed at $6.36 million private placement, further strengthening its financial position.

The company is trading at $0.62, and with approximately 70.1 million shares outstanding, the company is capitalized at $43.5 million.

For more information about Ergoresearch please visit their website at www.ergoresearch.com or call Sylvain Boucher, President and CEO at 450-973-6700 ext 213 or email sboucher@ergoresearch.com.

For a copy of the report, contact eResearch at www.eresearch.ca. While on their site, sign up for their free reports. eResearch does not receive a fee for the preparation and publication of StockPotentials reports.

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
604-684-5524
bmorgan@investmentpitch.com





This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: InvestmentPitch via Thomson Reuters ONE

HUG#1705704

GlobeNewswire

Comment on this story

Share